Stay ahead with the latest tech breakthroughs, industry trends, and cutting-edge news on our Innovation Feed channel.
https://samirb.com.np/
https://samirb.com.np/
# AI #ChatGPT #Healthcare
OpenAI Says Over 40 Million Users Have Asked ChatGPT Healthcare Questions: Report
OpenAI reportedly says millions ask ChatGPT health questions, far beyond typical use.
Key highlights
- More than 5% of all ChatGPT messages are health-related
- 7 in 10 healthcare chats occur outside clinic hours
- Health-focused performance emphasized with GPT-5
- Rural users contribute ~600k healthcare messages weekly
- 1.6–1.9 million weekly health-insurance questions
Read More: OpenAI Says Over 40 Million Users Have Asked ChatGPT Healthcare Questions: Report
OpenAI Says Over 40 Million Users Have Asked ChatGPT Healthcare Questions: Report
OpenAI reportedly says millions ask ChatGPT health questions, far beyond typical use.
Key highlights
- More than 5% of all ChatGPT messages are health-related
- 7 in 10 healthcare chats occur outside clinic hours
- Health-focused performance emphasized with GPT-5
- Rural users contribute ~600k healthcare messages weekly
- 1.6–1.9 million weekly health-insurance questions
Read More: OpenAI Says Over 40 Million Users Have Asked ChatGPT Healthcare Questions: Report
Lego has introduced new Smart Bricks with built‑in microchips at CES, calling them the company's biggest evolution in decades. A classic 2x4 brick can detect NFC tags in special tiles and minifigures, track the movement and position of other Smart Bricks, and add light and sound effects to physical builds.
In Lego Star Wars sets, the system can, for example, play "The Imperial March" when Emperor Palpatine is seated on his throne, let ships "battle" each other, and make cars register who crosses the finish line first or trigger an alert when they flip over. The new bricks form a Bluetooth mesh network and are set to debut in Star Wars kits starting March 1, 2026.
Read More
Insilico Medicine says its drug Rentosertib—the first medicine fully discovered and designed using artificial intelligence—could enter Phase 3 clinical trials within the next 18 months, marking the final stage before regulatory approval.
The drug targets idiopathic pulmonary fibrosis, a deadly lung disease that kills around 40,000 people in the US each year. In a Phase 2 trial involving 71 patients in China, Rentosertib improved lung function with few side effects.
Read More